1. Home
  2. INFU vs EARN Comparison

INFU vs EARN Comparison

Compare INFU & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InfuSystems Holdings Inc.

INFU

InfuSystems Holdings Inc.

HOLD

Current Price

$8.63

Market Cap

182.4M

Sector

Health Care

ML Signal

HOLD

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.57

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
INFU
EARN
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
182.4M
200.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
INFU
EARN
Price
$8.63
$5.57
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$14.50
$5.88
AVG Volume (30 Days)
118.2K
343.8K
Earning Date
03-03-2026
03-11-2026
Dividend Yield
N/A
17.17%
EPS Growth
271.43
N/A
EPS
0.26
N/A
Revenue
$141,054,000.00
$35,893,000.00
Revenue This Year
$8.82
$8.43
Revenue Next Year
$2.90
$17.28
P/E Ratio
$33.35
N/A
Revenue Growth
6.23
43.30
52 Week Low
$4.61
$4.33
52 Week High
$11.04
$6.82

Technical Indicators

Market Signals
Indicator
INFU
EARN
Relative Strength Index (RSI) 44.51 61.47
Support Level $8.34 $5.23
Resistance Level $8.82 $5.64
Average True Range (ATR) 0.36 0.11
MACD 0.00 0.02
Stochastic Oscillator 42.96 72.63

Price Performance

Historical Comparison
INFU
EARN

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: